이라디메드 코퍼레이션
US ˙ NasdaqGM ˙ US46266A1097

SecurityIRMD / IRADIMED CORPORATION
InstitutionMorgan Stanley
Latest Disclosed Ownership149,839 shares
Latest Disclosed Value $ 14,423,563
Morgan Stanley reports 11.21% increase in ownership of IRMD / IRADIMED CORPORATION

On May 15, 2026 - Morgan Stanley filed a 13F-HR form disclosing ownership of 149,839 shares of IRADIMED CORPORATION (US:IRMD) valued at $14,423,502 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on May 27, 2026 disclosing 134,731 shares of IRADIMED CORPORATION. This represents a change in shares of 11.21% during the quarter. The current value of the position is $14,020,435 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F IRADIMED COM 46266A109 149,839 15,108 11.21 14,424 10.05 0.0009
2026-05-27 2025-12-31 13F/A-1 IRADIMED COM 46266A109 134,731 7,529 5.92 13,107 44.80 0.0008
2026-02-13 2025-12-31 13F IRADIMED COM 46266A109 134,731 7,529 13,107 0.0008
2026-05-27 2025-09-30 13F/A-1 IRADIMED COM 46266A109 127,202 35,732 39.06 9,052 65.50 0.0005
2025-11-14 2025-09-30 13F IRADIMED COM 46266A109 127,202 35,732 9,052 0.0005
2025-08-15 2025-06-30 13F IRADIMED COM 46266A109 91,470 4,601 5.30 5,469 19.99 0.0004
2025-05-15 2025-03-31 13F IRADIMED COM 46266A109 86,869 -1,161 -1.32 4,559 -5.85 0.0003
2025-05-15 2024-12-31 13F/A-1 IRADIMED COM 46266A109 88,030 1,822 2.11 4,842 11.67 0.0003
2025-02-14 2024-12-31 13F IRADIMED COM 46266A109 88,030 1,822 4,842 0.0003
2025-05-14 2024-09-30 13F/A-2 IRADIMED COM 46266A109 86,208 -2,357 -2.66 4,335 11.41 0.0003
2025-02-14 2024-09-30 13F/A-1 IRADIMED COM 46266A109 86,208 -2,357 4,335 0.0003
2024-11-14 2024-09-30 13F IRADIMED COM 46266A109 86,208 -2,357 4,335 0.0003
2025-05-14 2024-06-30 13F/A-2 IRADIMED COM 46266A109 88,565 41,223 87.07 3,892 86.89 0.0003
2024-10-17 2024-06-30 13F/A-1 IRADIMED COM 46266A109 88,565 41,223 3,892 0.0003
2024-08-14 2024-06-30 13F IRADIMED COM 46266A109 88,565 41,223 3,892 0.0003
2024-10-17 2024-03-31 13F/A-2 IRADIMED COM 46266A109 47,342 -25,269 -34.80 2,083 -39.58 0.0002
2024-08-16 2024-03-31 13F/A-1 IRADIMED COM 46266A109 47,342 -25,269 2,083 0.0000
2024-05-15 2024-03-31 13F IRADIMED COM 46266A109 47,342 -25,269 2,083 0.0002
2024-08-16 2023-12-31 13F/A-1 IRADIMED COM 46266A109 72,611 19,204 35.96 3,447 45.46 0.0003
2024-02-13 2023-12-31 13F IRADIMED COM 46266A109 72,611 19,204 3,447 0.0003
2023-11-15 2023-09-30 13F IRADIMED COM 46266A109 53,407 14,016 35.58 2,370 26.01 0.0002
2023-08-14 2023-06-30 13F IRADIMED COM 46266A109 39,391 14,528 58.43 1,881 92.23 0.0002
2023-05-15 2023-03-31 13F IRADIMED COM 46266A109 24,863 -11,031 -30.73 978 -3.65 0.0001
2023-02-14 2022-12-31 13F IRADIMED COM 46266A109 35,894 -4,597 -11.35 1,015 -16.60 0.0001
2022-11-14 2022-09-30 13F IRADIMED COM 46266A109 40,491 -9,107 -18.36 1,217 -27.69 0.0002
2022-10-27 2022-06-30 13F/A-1 IRADIMED COM 46266A109 49,598 28,939 140.08 1,683 81.55 0.0002
2022-08-15 2022-06-30 13F IRADIMED COM 46266A109 49,598 28,939 1,683 0.0000
2022-10-27 2022-03-31 13F/A-1 IRADIMED COM 46266A109 20,659 -8,330 -28.74 927 -30.77 0.0001
2022-05-13 2022-03-31 13F IRADIMED COM 46266A109 20,659 -8,330 927 0.0001
2022-02-14 2021-12-31 13F IRADIMED COM 46266A109 28,989 14,837 104.84 1,339 181.89 0.0002
2021-11-15 2021-09-30 13F IRADIMED COM 46266A109 14,152 1,183 9.12 475 24.67 0.0001
2021-08-23 2021-06-30 13F/A-1 IRADIMED COM 46266A109 12,969 -19,633 -60.22 381 -54.64 0.0001
2021-08-16 2021-06-30 13F IRADIMED COM 46266A109 12,969 -19,633 381 0.0000
2021-05-17 2021-03-31 13F IRADIMED COM 46266A109 32,602 -26,736 -45.06 840 -37.87 0.0001
2021-02-16 2020-12-31 13F IRADIMED COM 46266A109 59,338 38,670 187.10 1,352 205.88 0.0002
2020-11-13 2020-09-30 13F IRADIMED COM 46266A109 20,668 -13,751 -39.95 442 -44.61 0.0001
2020-08-14 2020-06-30 13F IRADIMED COM 46266A109 34,419 -169 -0.49 798 8.13 0.0002
2020-05-26 2020-03-31 13F/A-1 IRADIMED COM 46266A109 34,588 19,875 135.08 738 114.53 0.0002
2020-05-15 2020-03-31 13F IRADIMED COM 46266A109 34,588 19,875 738 56.6938
2020-02-14 2019-12-31 13F IRADIMED COM 46266A109 14,713 -13,236 -47.36 344 -41.50 0.0001
2019-11-14 2019-09-30 13F IRADIMED COM 46266A109 27,949 14,831 113.06 588 119.40 0.0002
2019-08-14 2019-06-30 13F IRADIMED COM 46266A109 13,118 1,637 14.26 268 -16.77 0.0001
2019-05-15 2019-03-31 13F IRADIMED COM 46266A109 11,481 -6,967 -37.77 322 -28.60 0.0001
2019-02-14 2018-12-31 13F IRADIMED COM 46266A109 18,448 -7,579 -29.12 451 -53.36 0.0001
2019-04-23 2018-09-30 13F/A-2 IRADIMED COM 46266A109 26,027 595 2.34 967 83.14 0.0002
2018-11-20 2018-09-30 13F/A-1 IRADIMED COM 46266A109 26,027 0 967 0.0002
2018-11-14 2018-09-30 13F IRADIMED COM 46266A109 26,027 595 967
2019-04-23 2018-06-30 13F/A-1 IRADIMED COM 46266A109 25,432 5,463 27.36 528 83.97 0.0001
2018-08-14 2018-06-30 13F IRADIMED COM 46266A109 25,432 5,463 528
2019-04-23 2018-03-31 13F/A-1 IRADIMED COM 46266A109 19,969 -3,967 -16.57 287 -20.72 0.0001
2018-05-14 2018-03-31 13F IRADIMED COM 46266A109 19,969 -3,967 287
2019-04-23 2017-12-31 13F/A-1 IRADIMED COM 46266A109 23,936 -16,040 -40.12 362 -5.48 0.0001
2018-02-14 2017-12-31 13F IRADIMED COM 46266A109 23,936 -16,040 362
2017-11-14 2017-09-30 13F IRADIMED COM 46266A109 39,976 11,248 39.15 383 55.06 0.0001
2017-08-11 2017-06-30 13F IRADIMED COM 46266A109 28,728 -30,274 -51.31 247 -52.95 0.0001
2017-05-22 2017-03-31 13F/A-1 IRADIMED COM 46266A109 59,002 22,557 61.89 525 29.63 0.0002
2017-05-12 2017-03-31 13F IRADIMED COM 46266A109 59,002 525
2017-02-22 2016-12-31 13F/A-1 IRADIMED COM 46266A109 36,445 17,631 93.71 405 26.96 0.0001
2017-02-13 2016-12-31 13F IRADIMED COM 46266A109 36,445 405
2016-11-10 2016-09-30 13F IRADIMED COM 46266A109 18,814 5,082 37.01 319 6.69 0.0001
2016-08-12 2016-06-30 13F IRADIMED COM 46266A109 13,732 -6,984 -33.71 299 -24.69 0.0001
2016-05-12 2016-03-31 13F IRADIMED COM 46266A109 20,716 5,801 38.89 397 -5.02 0.0002
2016-02-09 2015-12-31 13F IRADIMED COM 46266A109 14,915 7,612 104.23 418 134.83 0.0002
2016-02-08 2015-09-30 13F/A-1 IRADIMED COM 46266A109 7,303 -23,477 -76.27 178 -75.14 0.0001
2015-11-09 2015-09-30 13F IRADIMED COM 46266A109 7,303 178
2015-08-12 2015-06-30 13F IRADIMED COM 46266A109 30,780 28,214 1,099.53 716 1,735.90 0.0002
2015-05-14 2015-03-31 13F IRADIMED COM 46266A109 2,566 1,648 179.52 39 225.00 0.0000
2015-02-13 2014-12-31 13F IRADIMED COM 46266A109 918 900 5,000.00 12 -69.23 0.0000
2014-12-16 2014-09-30 13F/A-1 IRADIMED COM 46266A109 18 18 0 0.0000
2014-11-14 2014-09-30 13F IRADIMED COM 46266A109 18 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.